LifeMD (LFMD) Cost of Revenue (2012 - 2025)

LifeMD's Cost of Revenue history runs 14 years deep, the most recent figure standing at $4.2 million for Q4 2025.

• Quarterly Cost of Revenue fell 37.78% year-over-year to $4.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $27.7 million (up 29.26% YoY) and the FY2025 annual result came in at $27.7 million, up 29.26% from the prior year.
• Cost of Revenue was $4.2 million for Q4 2025 at LifeMD, down from $7.4 million in the prior quarter.
• Across five years, Cost of Revenue topped out at $8.6 million in Q1 2025 and bottomed at $3.2 million in Q1 2021.
• A 5-year average of $5.2 million and a median of $4.9 million in 2023 frame the typical range for Cost of Revenue.
• Annual changes were most pronounced in 2021 — Cost of Revenue surged 204.16% — and 2025, when it plunged 37.78%.
• LifeMD's Cost of Revenue stood at $5.6 million in 2021, then fell by 26.94% to $4.1 million in 2022, then surged by 31.66% to $5.4 million in 2023, then gained by 27.01% to $6.8 million in 2024, then plunged by 37.78% to $4.2 million in 2025.
• Business Quant data shows LFMD's Cost of Revenue at $4.2 million in Q4 2025, $7.4 million in Q3 2025, and $7.4 million in Q2 2025.